Severe Symptomatic Hyponatremia Caused by Low Dose Oral Cyclophosphamide: A Case Report / 대한신장학회지
Korean Journal of Nephrology
;
: 647-650, 2011.
Artículo
en Inglés
| WPRIM
| ID: wpr-162488
ABSTRACT
Cyclophosphamide (CY), an alkylating agent, is frequently used in the treatment of various autoimmune disorders and malignancies. Acute hyponatremia is a well-known side effect of moderate to high dose intravenous CY treatment, but is rare in patients treated with low dose intravenous CY. We report the case of a severe symptomatic hyponatremia in a 68-year-old woman with renal impairment who was treated with oral CY (100 mg/day) for anti-neutrophil cytoplasmic antibody (ANCA) associated glomerulonephritis (GN). This case demonstrates that even oral CY could be associated with life threatening acute hyponatremia and should be used with caution.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Anticuerpos Anticitoplasma de Neutrófilos
/
Ciclofosfamida
/
Vasculitis Asociada a Anticuerpos Citoplasmáticos Antineutrófilos
/
Glomerulonefritis
/
Hiponatremia
Tipo de estudio:
Estudio diagnóstico
Límite:
Anciano
/
Femenino
/
Humanos
Idioma:
Inglés
Revista:
Korean Journal of Nephrology
Año:
2011
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS